Feng Wen, Tianhai Lin, Ping Tan, Jiani Deng, Min Ren, Mengni Zhang, Xiaonan Zheng, Peng Zhang, Yali Shen. "Long-term results of a phase 2 study of neoadjuvant chemotherapy combined with tislelizumab followed by radiotherapy for bladder-preserving treatment in selected high-risk/locally advanced muscle invasive urothelial bladder cancer (HOPE-02).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.786